| Prolific. ac—A subject pool for online experiments S Palan, C Schitter Journal of Behavioral and Experimental Finance 17, 22-27, 2018 | 2845 | 2018 |
| A review of bubbles and crashes in experimental asset markets S Palan A Collection of Surveys on Market Experiments, 197-217, 2013 | 316 | 2013 |
| To see is to believe: Common expectations in experimental asset markets SL Cheung, M Hedegaard, S Palan European Economic Review 66, 84-96, 2014 | 122 | 2014 |
| MRSA transmission on a neonatal intensive care unit: epidemiological and genome-based phylogenetic analyses U Nübel, M Nachtnebel, G Falkenhorst, J Benzler, J Hecht, M Kube, ... PloS one 8 (1), e54898, 2013 | 94 | 2013 |
| Inducing low-carbon investment in the electric power industry through a price floor for emissions trading A Brauneis, R Mestel, S Palan Energy Policy 53, 190-204, 2013 | 89 | 2013 |
| Nobel and novice: Author prominence affects peer review J Huber, S Inoua, R Kerschbamer, C König-Kersting, S Palan, VL Smith Proceedings of the National Academy of Sciences 119 (41), e2205779119, 2022 | 75 | 2022 |
| Two heads are less bubbly than one: team decision-making in an experimental asset market SL Cheung, S Palan Experimental Economics 15, 373-397, 2012 | 68 | 2012 |
| Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG)(AWMF 055/066) J Thoden, A Potthoff, JR Bogner, NH Brockmeyer, S Esser, ... Infection 41, 91-115, 2013 | 60 | 2013 |
| Does investor risk perception drive asset prices in markets? Experimental evidence J Huber, S Palan, S Zeisberger Journal of banking & Finance 108, 105635, 2019 | 54 | 2019 |
| GIMS—Software for asset market experiments S Palan Journal of behavioral and experimental finance 5, 1-14, 2015 | 54 | 2015 |
| Nonstandard errors AJ Menkveld, A Dreber, F Holzmeister, J Huber, M Johannesson, ... The Journal of Finance, 2023 | 50 | 2023 |
| Erster Erfahrungsaustausch zur H1N1-Pandemie in Deutschland 2009/2010: Bericht über einen Workshop am 22. und 23. März 2010 in Berlin G Krause, A Gilsdorf, J Becker, K Bradt, C Dreweck, B Gärtner, J Löwer, ... Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 53 (5), 510, 2010 | 46 | 2010 |
| Bubbles and crashes in experimental asset markets S Palan Springer Science & Business Media, 2009 | 41 | 2009 |
| The efficient market hypothesis and its validity in today's markets S Palan Grin Verlag, 2004 | 41 | 2004 |
| Enhanced surveillance during a large outbreak of bloody diarrhoea and haemolytic uraemic syndrome caused by Shiga toxin/verotoxin-producing Escherichia coli in Germany, May to … M Wadl, T Rieck, M Nachtnebel, B Greutélaers, M An der Heiden, ... Eurosurveillance 16 (24), 2011 | 38 | 2011 |
| Candida infection in HIV positive patients 1985–2007 C Traeder, S Kowoll, K Arastéh Mycoses 51, 58-61, 2008 | 38 | 2008 |
| Immaterial and monetary gifts in economic transactions: Evidence from the field M Kirchler, S Palan Experimental economics 21, 205-230, 2018 | 25 | 2018 |
| Molecular typing of toxic shock syndrome toxin-1-and Enterotoxin A-producing methicillin-sensitive Staphylococcus aureus isolates from an outbreak in a neonatal intensive care unit F Layer, A Sanchini, B Strommenger, C Cuny, AC Breier, H Proquitté, ... International Journal of Medical Microbiology 305 (7), 790-798, 2015 | 23 | 2015 |
| Lessons from a one-year hospital-based surveillance of acute respiratory infections in Berlin-comparing case definitions to monitor influenza M Nachtnebel, B Greutelaers, G Falkenhorst, P Jorgensen, M Dehnert, ... BMC Public Health 12, 1-9, 2012 | 23 | 2012 |
| Prospective hospital-based case–control study to assess the effectiveness of pandemic influenza A (H1N1) pdm09 vaccination and risk factors for hospitalization in 2009–2010 … W Hellenbrand, P Jorgensen, B Schweiger, G Falkenhorst, M Nachtnebel, ... BMC Infectious Diseases 12, 1-12, 2012 | 22 | 2012 |
